A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D

B. L. Riggs, John Christopher G. Gallagher, H. F. DeLuca, A. J. Edis, P. W. Lambert, C. D. Arnaud

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Although most patients with postmenopausal osteoporosis have normal or low values for serum immunoreactive parathyroid hormone (iPTH), the authors have reported previously that a small subset (about 10% of the total group) have increased values. The authors studied three patients representative of this latter group. Serum iPTH was two to three times higher than the age-adjusted normal mean, serum ionized calcium and total calcium were in the lower half of the normal range, and serum 1,25-dihydroxyvitamin D [1,25(OH) 2D] was in the low-normal range. Six months of treatment of one patients with 0.5 μg/day of synthetic 1,25(OH) 2D improved calcium absorption and balance; however, serum iPTH remained high. After surgical removal of 1,010 mg of hyperplastic parathyroid tissue, serum iPTH decreased to normal. These and other data suggest that increased serum iPTH in these patients was caused by secondary hyperparathyroidism, possibly because of inadequate conversion of 25-OH-D to 1,25(OH) 2D.

Original languageEnglish
Pages (from-to)701-706
Number of pages6
JournalMayo Clinic Proceedings
Volume53
Issue number11
StatePublished - 1978
Externally publishedYes

Fingerprint

Parathyroid Hormone
Osteoporosis
Serum
Calcium
Reference Values
Patient Advocacy
Postmenopausal Osteoporosis
Secondary Hyperparathyroidism
1,25-dihydroxyvitamin D

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D. / Riggs, B. L.; Gallagher, John Christopher G.; DeLuca, H. F.; Edis, A. J.; Lambert, P. W.; Arnaud, C. D.

In: Mayo Clinic Proceedings, Vol. 53, No. 11, 1978, p. 701-706.

Research output: Contribution to journalArticle

@article{66d45dd71a9e4e7e81bc11ce8e1513f3,
title = "A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D",
abstract = "Although most patients with postmenopausal osteoporosis have normal or low values for serum immunoreactive parathyroid hormone (iPTH), the authors have reported previously that a small subset (about 10{\%} of the total group) have increased values. The authors studied three patients representative of this latter group. Serum iPTH was two to three times higher than the age-adjusted normal mean, serum ionized calcium and total calcium were in the lower half of the normal range, and serum 1,25-dihydroxyvitamin D [1,25(OH) 2D] was in the low-normal range. Six months of treatment of one patients with 0.5 μg/day of synthetic 1,25(OH) 2D improved calcium absorption and balance; however, serum iPTH remained high. After surgical removal of 1,010 mg of hyperplastic parathyroid tissue, serum iPTH decreased to normal. These and other data suggest that increased serum iPTH in these patients was caused by secondary hyperparathyroidism, possibly because of inadequate conversion of 25-OH-D to 1,25(OH) 2D.",
author = "Riggs, {B. L.} and Gallagher, {John Christopher G.} and DeLuca, {H. F.} and Edis, {A. J.} and Lambert, {P. W.} and Arnaud, {C. D.}",
year = "1978",
language = "English",
volume = "53",
pages = "701--706",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "11",

}

TY - JOUR

T1 - A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D

AU - Riggs, B. L.

AU - Gallagher, John Christopher G.

AU - DeLuca, H. F.

AU - Edis, A. J.

AU - Lambert, P. W.

AU - Arnaud, C. D.

PY - 1978

Y1 - 1978

N2 - Although most patients with postmenopausal osteoporosis have normal or low values for serum immunoreactive parathyroid hormone (iPTH), the authors have reported previously that a small subset (about 10% of the total group) have increased values. The authors studied three patients representative of this latter group. Serum iPTH was two to three times higher than the age-adjusted normal mean, serum ionized calcium and total calcium were in the lower half of the normal range, and serum 1,25-dihydroxyvitamin D [1,25(OH) 2D] was in the low-normal range. Six months of treatment of one patients with 0.5 μg/day of synthetic 1,25(OH) 2D improved calcium absorption and balance; however, serum iPTH remained high. After surgical removal of 1,010 mg of hyperplastic parathyroid tissue, serum iPTH decreased to normal. These and other data suggest that increased serum iPTH in these patients was caused by secondary hyperparathyroidism, possibly because of inadequate conversion of 25-OH-D to 1,25(OH) 2D.

AB - Although most patients with postmenopausal osteoporosis have normal or low values for serum immunoreactive parathyroid hormone (iPTH), the authors have reported previously that a small subset (about 10% of the total group) have increased values. The authors studied three patients representative of this latter group. Serum iPTH was two to three times higher than the age-adjusted normal mean, serum ionized calcium and total calcium were in the lower half of the normal range, and serum 1,25-dihydroxyvitamin D [1,25(OH) 2D] was in the low-normal range. Six months of treatment of one patients with 0.5 μg/day of synthetic 1,25(OH) 2D improved calcium absorption and balance; however, serum iPTH remained high. After surgical removal of 1,010 mg of hyperplastic parathyroid tissue, serum iPTH decreased to normal. These and other data suggest that increased serum iPTH in these patients was caused by secondary hyperparathyroidism, possibly because of inadequate conversion of 25-OH-D to 1,25(OH) 2D.

UR - http://www.scopus.com/inward/record.url?scp=0018126938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018126938&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 701

EP - 706

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 11

ER -